Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000152

Chairperson & CEO sold 9,500 shares at an average $477.42 ($4,535,480)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

13 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-29 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-09-29 Sale : show line 2 in the form 10b5-1 −400 $472.05 $188,818 333,543 I
2026-09-29 Sale : show line 3 in the form 10b5-1 −449 $472.97 $212,363 333,094 I
2026-09-29 Sale : show line 4 in the form 10b5-1 −80 $473.86 $37,908 333,014 I
2026-09-29 Sale : show line 5 in the form 10b5-1 −552 $475.12 $262,263 332,462 I
2026-09-29 Sale : show line 6 in the form 10b5-1 −1,395 $476.10 $664,160 331,067 I
2026-09-29 Sale : show line 7 in the form 10b5-1 −2,135 $477.09 $1,018,581 328,932 I
2026-09-29 Sale : show line 8 in the form 10b5-1 −2,309 $478.10 $1,103,923 326,623 I
Open-market sales · 9,500 sh · avg $477.42 · $4,535,480

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-29 Exercise or conversion : show line 14 in the form 10b5-1 Stock Option −9,500 337,910 I
Loading xslF345X06/primarydocument.xml…